ALR2-IN-6
ALR2-IN-6 (compound 9) is a potent and competitive ALR2 inhibitor with a Ki of 0.064 μM. ALR2-IN-6 can be used in the study of neuropathy, retinopathy, and nephropathy[1].
Product Specifications
UNSPSC
12352005
Target
Aldose Reductase
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Neurological Disease
Smiles
O=C1N(/N=C/C2=CC=C(Br)C=C2F)C(C3CCCCC3)=NC4=C1C=CC=C4
Molecular Formula
C21H19BrFN3O
Molecular Weight
428.30
References & Citations
[1]Tokalı P, et al. Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4 (3H) -one derivatives with 4-Bromo-2-Fluorobenzene functionality. Bioorg Chem. 2025 May 19;162:108614.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC683799-100 1x 100 µL
Cytokeratin 6A (KRT6A) (Basal Cell Marker) (rKRT6A/2100), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
